MIRA INFORM REPORT

 

 

Report Date :

02.01.2013

 

IDENTIFICATION DETAILS

 

Name :

PINNACLE  CHEMMED  CO.,  LTD.

 

 

Registered Office :

31/56  Soi  Ladplakao  72,  Yaek  1, Ladplakao  Road,  Anusawaree, Bangkhen,  Bangkok  10220

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

02.10.2009

 

 

Com. Reg. No.:

0135552009281

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Importer  and  Distributor of Pharmaceutical  Chemicals

 

 

No. of Employees :

9

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Thailand

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

THAILAND - ECONOMIC OVERVIEW

 

With a well-developed infrastructure, a free-enterprise economy, generally pro-investment policies, and strong export industries, Thailand enjoyed solid growth from 2000 to 2007 - averaging more than 4% per year - as it recovered from the Asian financial crisis of 1997-98. Thai exports - mostly machinery and electronic components, agricultural commodities, and jewelry - continue to drive the economy, accounting for more than half of GDP. The global financial crisis of 2008-09 severely cut Thailand's exports, with most sectors experiencing double-digit drops. In 2009, the economy contracted 2.3%. In 2010, Thailand's economy expanded 7.8%, its fastest pace since 1995, as exports rebounded from their depressed 2009 level. Steady economic growth at just below 4% during the first three quarters of 2011 was interrupted by historic flooding in October and November in the industrial areas north of Bangkok, crippling the manufacturing sector and leading to a revised growth rate of only 0.1% for the year. The industrial sector is poised to recover from the second quarter of 2012 onward, however, and the government anticipates the economy will probably grow between 5.5 and 6.5% for 2012, while private sector forecasts range between 3.8% and 5.7%.

Source : CIA


Company name

 

PINNACLE  CHEMMED  CO.,  LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           31/56  SOI  LADPLAKAO  72,  YAEK  1,

LADPLAKAO  ROAD,  ANUSAWAREE,

BANGKHEN,  BANGKOK  10220

TELEPHONE                                         :           [66]   2986-3980-2

FAX                                                      :           [66]   2986-3983

E-MAIL  ADDRESS                                :           chemmedline@gmail.com

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                                     :           2009

REGISTRATION  NO.                           :           0135552009281

TAX  ID  NO.                                         :           3033713190

CAPITAL REGISTERED                         :           BHT.   1,000,000

CAPITAL PAID-UP                                :           BHT.   1,000,000

SHAREHOLDER’S  PROPORTION         :           THAI     :    100%

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR. CHAINARONG  RUNGROJKITTIKUL,  THAI

                                                                        MANAGING  DIRECTOR           

 

NO.  OF  STAFF                                   :           9

LINES  OF  BUSINESS                          :           PHARMACEUTICAL  CHEMICALS

                                                                        IMPORTER  AND  DISTRIBUTOR

                                                                         

 

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           FAIR  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  FAIR  PERFORMANCE             

 

 

 

 

 

 


HISTORY

 

The  subject  was  established  on October  2,  2009 as  a  private  limited  company  under  the  originally  registered  name  “Core  Pharmaceutical  Co.,  Ltd.”  by  Thai groups.  On  July  5,  2010,  its  name was  changed  to  PINNACLE  CHEMMED CO.,  LTD.   The  business’s  objective  is  to  import  and  distribute  pharmaceutical  and  chemicals  for  pharmaceutical  industry.  It  currently  employs  9  staff.  

 

The  subject’s  registered  address  is 31/56  Soi  Ladplakao 72,  Yaek  1,  Ladplakao  Rd.,  Anusawaree, Bangkhen,  Bangkok 10220,  and  this  is  the  subject’s  current  operation  address.  

 

 

THE  BOARD  OF  DIRECTOR

 

     Name

 

Nationality

Age

 

 

 

 

Mr. Chainarong  Rungrojkittikul

 

Thai

52

Mrs.  Armorn  Rungrojkittikul

 

Thai

44

 

 

AUTHORIZED  PERSON

 

One  of  the  above  directors  can  sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mr. Chainarong  Rungrojkittikul  is  the  Managing  Director.

He  is  Thai  nationality  with  the  age  of  52 years  old.  

 

 

BUSINESS  OPERATIONS

 

The  subject’s  core  business  is  engaged  in  importing  and  distributing  various  kinds  of  chemicals  for  pharmaceutical  industry.  Range  of  pharmaceutical  chemicals  are  included  Phenyl  Salicylate,  Co-enzyme,  Chloramphenicol  Sodium  Succinate  Lyophilised,  Sterilized,  Trazodone  HCL,  Tranexamic  acid,  Phenyl  Salicylate,  Norethisterone,  Tramadol  HCL,  Cefaclor,  Mianserin  HCL,  Tranexamic  acid,  Bisacodyl,  Loratadine,  Nimesulide,  etc.,  as  well  as  pharmaceutical  products.

 

PURCHASE

 

The products are  purchased  from  suppliers both  domestic and  overseas,  mainly  India,  Germany,  U.S.A.,  United  Kindom  and  Republic  of  China.

 

 

 

MAJOR  SUPPLIERS

 

Haihang  Industry  Co.,  Ltd.                               :  Republic  of  China

Jinan  Great  Chemical  Industry  Co.,  Ltd.          :  Republic  of  China

Santa  Cruz  Biotechnology  Inc.                         :  U.S.A.

 

SALES 

 

100%  of  the  products  is  sold  locally  by  wholesale  to  manufacturers  and  end-users.

 

 

RELATED  AND  AFFILIATED  COMPANIES

 

Chemmed  Line  Co.,  Ltd.

Business  Type  :  Importer  and  distributor  of  pharmaceutical  chemicals.

 

Generic  Vet  Chem  Co.,  Ltd.

Business  Type  :  Importer  and  distributor  of  veterinary  products.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  T/T.

 

 

BANKING

 

Kasikornbank  Public  Co.,  Ltd.

 


EMPLOYMENT

 

The  subject  employs  9 staff.  

 

 

LOCATION  DETAILS

 

The  premise  is  rented  for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial/residential  area.

 

Branch/Warehouse :

 

111/14  Phrayasurane  Rd.,  Samwa  Tawan-tok,  Klongsamwa,  Bangkok  10510.

 

 

REMARK

 

MAXIMUM  CREDIT  SHOULD  BE  GRANTED  AT  US$ 120,000.

 

 

COMMENT

 

The  subject  is an  importer  and  distributor  of  pharmaceutical  and  chemical  for  pharmaceutical  industry.   Its  business  in  2011  was  outstanding,  as  well  as  remaining 

upbeat  as   its  products  have  been  widely  used  in  pharmaceutical  industry.   Domestic 

consumption  also  maintains  a  good  level.   Its  business  trend  is  expanding  steadily. 

 

 

FINANCIAL  INFORMATION

 

The  capital  was  registered  at  Bht. 1,000,000  divided  into 10,000  shares of  Bht. 100  each  with  fully  paid.

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at  April  30,  2012]

 

       NAME

HOLDING

%

 

 

 

Mr. Chainarong  Rungrojkittikul

Nationality:  Thai

Address     :  138/76  Moo  1,  Banklang,  Muang, 

                     Pathumthani

5,000

50.00

Mrs. Armorn  Rungrojkittikul

Nationality:  Thai

Address     :  138/76  Moo  1,  Banklang,  Muang, 

                     Pathumthani

4,000

40.00

Ms. Sopa  Tawachdam

Nationality:  Thai

Address     :  31/56  Ladplakao  72  Rd.,  Anusawaree, 

                     Bangkhen,  Bangkok

  230

2.30

Ms. Muthita  Longchantuek

Nationality:  Thai

Address     :  14/251  Soi  Ramindra 17,   Anusawaree, 

                     Bangkhen,  Bangkok

  225

2.25

Ms. Amorn  Tuaykaew

Nationality:  Thai

Address     :  9  Moo  6,  Jarakaemark,  Prakonechai, 

                     Buriram

  195

1.95

Mrs. Patcharee  Suwansri

Nationality:  Thai

Address     :  308/368  Moo  3,  Taladbangkhen,  Laksi, 

                     Bangkok

  180

1.80

Mrs. Vilai  Dokmaichan

Nationality:  Thai

Address     :  33/3  Moo  5,  Anusawaree,  Bangkhen, 

                     Bangkok

  170

1.70

Total  Shareholders  :   7

 

Share  Structure  [as  at  April  30,  2012]

 

Nationality

Shareholders

No. of  Share

% Shares

 

 

 

 

Thai

7

10,000

100.00

Foreign

-

-

-

 

Total

 

7

 

10,000

 

100.00

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC  ACCOUNTANT  NO. :

 

Mr. Dolawat  Aptwattanaporn  No.  8488

 

 

BALANCE SHEET [BAHT]

 

The  latest  financial  figures  published  for  December  31,  2011  &  2010  were :

          

ASSETS

                                                                                                 

Current Assets

2011

2010

 

 

 

Cash  and Cash Equivalent

6,895,063.04

910,371.99

Trade Account & Notes Receivable

72,647,501.77

3,137,851.51

Inventories

23,371,117.19

2,264,209.53

Other Current  Liabilities

133,052.88

1,856.64

 

 

 

Total  Current  Assets                

103,046,734.88

6,314,289.67

 

 

 

Fixed  Assets   

3,293,259.56

4,118,363.83

Long-term Lending to Person or Related Company

1,500,000.00

-

Guarantee  and  Deposit

2,500.00

2,500.00

 

Total  Assets                 

 

107,842,494.44

 

10,435,153.50

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY [BAHT]

 

 

Current Liabilities

2011

2010

 

 

 

Accrued Expenses

73,993,384.12

4,702,095.67

Current Portion of  Lease Contract  Payable

524,750.04

481,020.87

Other Current Liabilities

549,869.17

 -

 

 

 

Total Current Liabilities

75,068,003.33

5,183,116.54

 

Long-term Loan from Person or

   Related Company

 

 

27,847,427.83

 

 

2,540,000.00

Lease Contract  Payable,  net

1,093,229.09

1,617,979.13

 

Total  Liabilities            

 

104,008,660.25

 

9,341,095.67

 

 

 

Shareholders’ Equity

 

 

 

 

 

 Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital  10,000  shares

 

 

1,000,000.00

 

 

1,000,000.00

 

 

 

Capital  Paid                      

1,000,000.00

1,000,000.00

Retained  Earning- Unappropriated

2,833,834.19

94,057.83

 

Total Shareholders' Equity

 

3,833,834.19

 

1,094,057.83

 

Total Liabilities  &  Shareholders'  Equity

 

107,842,494.44

 

10,435,153.50

 


 

PROFIT  &  LOSS  ACCOUNT

 

 

Revenue

2011

2010

 

 

 

Sales  Income

140,239,720.30

2,823,000.71

 

Total  Revenues         

 

140,239,720.30

 

2,823,000.71

 

Expenses

 

 

 

 

 

Cost  of  Goods Sold

125,217,115.52

2,469,512.57

Selling Expenses

4,000,300.00

23,115.00

Administrative  Expenses

3,521,041.25

191,552.10

Other Expenses

2,619,123.30

27,712.11

 

Total Expenses             

 

135,357,580.07

 

2,711,891.78

 

 

 

Profit/[Loss] before Financial Cost  &

   Income Tax

 

4,882,140.23

 

111,108.93

Financial Cost

[1,089,994.70]

[3,331.10]

 

Profit  before  Income Tax

 

3,792,145.53

 

107,777.83

Income Tax

[1,052,369.17]

-

 

 

 

Net  Profit / [Loss]

2,739,776.36

107,777.83

 


 

FINANCIAL  ANALYSIS

 

ITEM

UNIT

2011

2010

 

 

 

 

LIQUIDITY RATIO

 

 

 

CURRENT RATIO

TIMES

1.37

1.22

QUICK RATIO

TIMES

1.06

0.78

 

 

 

 

ACTIVITY RATIO

 

 

 

FIXED ASSETS TURNOVER

TIMES

42.58

0.69

TOTAL ASSETS TURNOVER

TIMES

1.30

0.27

INVENTORY CONVERSION PERIOD

DAYS

68.13

334.66

INVENTORY TURNOVER

TIMES

5.36

1.09

RECEIVABLES CONVERSION PERIOD

DAYS

189.08

405.71

RECEIVABLES TURNOVER

TIMES

1.93

0.90

PAYABLES CONVERSION PERIOD

DAYS

-

-

CASH CONVERSION CYCLE

DAYS

257.20

740.36

 

 

 

 

PROFITABILITY RATIO

 

 

 

COST OF GOODS SOLD

%

89.29

87.48

SELLING & ADMINISTRATION

%

5.36

7.60

INTEREST

%

0.78

0.12

GROSS PROFIT MARGIN

%

10.71

12.52

NET PROFIT MARGIN BEFORE EX. ITEM

%

3.48

3.94

NET PROFIT MARGIN

%

1.95

3.82

RETURN ON EQUITY

%

71.46

9.85

RETURN ON ASSET

%

2.54

1.03

EARNING PER SHARE

BAHT

273.98

10.78

 

 

 

 

LEVERAGE RATIO

 

 

 

DEBT RATIO

TIMES

0.96

0.90

DEBT TO EQUITY RATIO

TIMES

27.13

8.54

TIME INTEREST EARNED

TIMES

4.48

33.36

 

 

 

 

ANNUAL GROWTH

 

 

 

SALES GROWTH

%

4,867.75

 

OPERATING PROFIT

%

4,294.01

 

NET PROFIT

%

2,442.06

 

FIXED ASSETS

%

(20.03)

 

TOTAL ASSETS

%

933.45

 

 

 


 

 

PROFITABILITY RATIO

 

Gross Profit Margin

10.71

Deteriorated

Industrial Average

23.49

Net Profit Margin

1.95

Satisfactory

Industrial Average

2.23

Return on Assets

2.54

Acceptable

Industrial Average

4.38

Return on Equity

71.46

Impressive

Industrial Average

11.28

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from revenues after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. The company's figure is 10.71%. When compared with the industry average, the ratio of the company was lower, indicated that company was originated from  the  problems with control over its costs.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. The company's figure is 1.95%. When compared with the industry average, the ratio of the company was lower.

 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. When compared with the industry average, it was lower, the company's figure is 2.54%.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. Return on Equity ratio is 71.46%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit  in a dominant position within its industry.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Uptrend

Return on Equity                        Downtrend

 

 

LIQUIDITY RATIO

 

Current Ratio

1.37

Satisfactory

Industrial Average

1.66

Quick Ratio

1.06

 

 

 

Cash Conversion Cycle

257.20

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 1.37 times in 2011, increased from 1.22 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was lower.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 1.06 times in 2011, increased from 0.78 times, although excluding inventory so the company still have good short-term financial strength.

 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for 258 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Uptrend


 

 

 

LEVERAGE RATIO

 

Debt Ratio

0.96

Acceptable

Industrial Average

0.59

Debt to Equity Ratio

27.13

Risky

Industrial Average

1.40

Times Interest Earned

4.48

Impressive

Industrial Average

4.39

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that the company is using less leverage and has a stronger equity position.

 

Times Interest Earned measuring a company's ability to meet its debt obligations. Ratio is 4.48 higher than 1, so the company can pay interest expenses on outstanding debt.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.96 greater than 0.5, most of the company's assets are financed through debt.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Downtrend

Times Interest Earned                Uptrend

 

 

ACTIVITY RATIO

 

Fixed Assets Turnover

42.58

Impressive

Industrial Average

9.02

Total Assets Turnover

1.30

Acceptable

Industrial Average

1.94

Inventory Conversion Period

68.13

 

 

 

Inventory Turnover

5.36

Impressive

Industrial Average

3.98

Receivables Conversion Period

189.08

 

 

 

Receivables Turnover

1.93

Acceptable

Industrial Average

2.86

Payables Conversion Period

-

 

 

 

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Downtrend

Total Assets Turnover                 Downtrend

Inventory Turnover                      Downtrend

Receivables Turnover                  Downtrend

 

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.83

UK Pound

1

Rs.89.22

Euro

1

Rs.72.48

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.